Insulin Resistance: The Hidden Driver of Modern Disease
Up to 88% of Americans have some degree of metabolic dysfunction. Insulin resistance often has no obvious symptoms — until it does.
A widely cited analysis of NHANES data concluded that only about 12% of American adults are metabolically healthy — meaning waist circumference, glucose, blood pressure, triglycerides, and HDL all in optimal range without medication. Flip that statistic around and it's startling: the overwhelming majority of adults show at least one sign of metabolic dysfunction, and insulin resistance is the common thread running through most of them.
What insulin resistance actually is
Insulin's job is to move glucose out of the bloodstream and into cells. When cells — primarily muscle and liver — become less responsive to that signal, the pancreas compensates by producing more insulin. For years, even decades, this compensation works: glucose stays normal while insulin quietly climbs.
That's what makes insulin resistance so insidious. Standard annual blood work measures the glucose (which looks fine) and not the insulin (which is screaming). By the time fasting glucose crosses into the prediabetic range, the underlying process is old news.
Why it matters far beyond diabetes
Insulin resistance is best understood not as "pre-diabetes" but as a root process implicated across the diseases that dominate modern mortality:
- Cardiovascular disease: hyperinsulinemia drives hypertension, elevates triglycerides, lowers HDL, and shifts LDL toward the small, dense particles most associated with plaque.
- Fatty liver disease: excess insulin promotes fat storage in the liver, which in turn worsens insulin resistance — a self-reinforcing loop.
- Cognitive decline: Alzheimer's disease has been called "type 3 diabetes" in research literature because of the strong links between insulin signaling and brain health.
- Certain cancers and PCOS: both show robust associations with hyperinsulinemia.
How to detect it early
You don't need exotic testing. A fasting insulin drawn with your fasting glucose lets a clinician calculate HOMA-IR, a validated index of insulin resistance. The triglyceride-to-HDL ratio from a standard lipid panel is a solid free proxy. Waist circumference — more than BMI — tracks the visceral fat that drives the process.
Continuous glucose monitors, once diabetes-only devices, are increasingly used to see how individual meals, sleep loss, and stress move your glucose in real time. They're not necessary for everyone, but for the data-motivated they turn an abstraction into feedback.
The reversibility story
Here is the genuinely good news: insulin resistance is among the most reversible major health conditions. Skeletal muscle is the largest glucose sink in the body, and it's trainable. Resistance training increases both the size of the sink and the number of insulin-independent glucose transporters. Even a single bout of exercise measurably improves insulin sensitivity for 24–48 hours.
Diet quality (particularly protein adequacy and reduction of refined carbohydrate), sleep, and weight loss compound the effect. In the DiRECT trial, structured weight loss put nearly half of participants' type 2 diabetes into remission — and insulin resistance responds earlier and more easily than established diabetes.
The first step is measurement. If you've never had fasting insulin drawn alongside your glucose, that single addition to your next lab order — reviewed by a licensed provider — can pull a decade-long process out of the shadows.
Written by Jack Psaras — Founder, VitalWay Health
Portions of this article were drafted with the assistance of AI and reviewed by the author before publication. This content is for informational purposes only and is not medical advice — always consult a licensed healthcare provider about your individual situation.